Literature DB >> 27311330

Can Physicians Affect Patient Adherence With Medication?

Sergei Koulayev1, Emilia Simeonova2, Niels Skipper3.   

Abstract

Non-compliance with medication therapy remains an unsolved and expensive problem for healthcare systems around the world, yet we know little about the factors that affect a patient's decision to follow treatment recommendations. In particular, there is little evidence on the extent to which doctors can influence patient adherence behavior. This study uses a unique panel dataset comprising all prescription drug users, physicians, and all prescription drug sales in Denmark over 7 years to analyze the contributions of doctor-specific, patient-specific, and drug-specific factors to the adherence decision. We find that physicians exert substantial influence on patient compliance. Further, the quality of the match between a doctor and a patient accounts for a substantial portion of the variation in adherence outcomes. This suggests that the sorting of patients across doctors is an important mechanism that affects patient adherence beyond the effects of individual patient-specific and physician-specific factors.
Copyright © 2016 John Wiley & Sons, Ltd. Copyright © 2016 John Wiley & Sons, Ltd.

Entities:  

Keywords:  medication adherence; physician behavior; prescription drugs

Mesh:

Substances:

Year:  2016        PMID: 27311330     DOI: 10.1002/hec.3357

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


  6 in total

1.  Big Data: Will It Improve Patient-Centered Care?

Authors:  Denzil G Fiebig
Journal:  Patient       Date:  2017-04       Impact factor: 3.883

2.  Patient compliance with venous thromboembolism prophylaxis (VTE).

Authors:  John Ross Blackwell; Parag Raval; John-Patrick Quigley; Amit Patel; Donald McBride
Journal:  J Clin Orthop Trauma       Date:  2017-04-14

3.  Primary care physician practice styles and patient care: Evidence from physician exits in Medicare.

Authors:  Itzik Fadlon; Jessica Van Parys
Journal:  J Health Econ       Date:  2020-04-01       Impact factor: 3.883

4.  Physician-Level Cost Control Measures and Regional Variation of Biosimilar Utilization in Germany.

Authors:  Katharina E Blankart; Friederike Arndt
Journal:  Int J Environ Res Public Health       Date:  2020-06-09       Impact factor: 3.390

5.  A longitudinal assessment of chronic care pathways in real-life: self-care and outcomes of chronic heart failure patients in Tuscany.

Authors:  E Guidotti; F Pennucci; A Valleggi; S De Rosis; C Passino
Journal:  BMC Health Serv Res       Date:  2022-09-10       Impact factor: 2.908

6.  Adherence during COVID-19: The role of aging and socio-economics status in shaping drug utilization.

Authors:  Cinzia Di Novi; Lucia Leporatti; Rosella Levaggi; Marcello Montefiori
Journal:  J Econ Behav Organ       Date:  2022-10-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.